Pulmonx Corp
LUNG
DELAYED 1 MONTH
14 insider filings · Latest: Jun 5, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 3 8:18 PM | Srikanth RadhakrishnanChief Science &Techn. Officer | Sale | 14,497 | $1.54 | $22.3K | 331,239(D) | View → |
| Jun 1, 2026 | Jun 3 8:17 PM | David Aaron LehmanGENERAL COUNSEL | Sale | 14,594 | $1.54 | $22.5K | 376,161(D) | View → |
| Jun 1, 2026 | Jun 3 8:16 PM | Geoffrey Beran RoseCHIEF COMMERCIAL OFFICER | Sale | 8,023 | $1.54 | $12.4K | 457,711(D) | View → |
| Jun 2, 2026 | Jun 3 8:15 PM | Glendon E. French IIIDirector, President and CEO | Sale | 13,511 | $1.57 | $21.2K | 1,178,162(D) | View → |
| Jun 1, 2026 | Jun 3 8:15 PM | Glendon E. French IIIDirector, President and CEO | Sale | 42,638 | $1.54 | $65.7K | 1,191,673(D) | View → |
| Mar 2, 2026 | Mar 5 12:07 AM | Srikanth RadhakrishnanChief Science &Techn. Officer | Sale | 10,483 | $1.43 | $15.0K | 170,736(D) | View → |
| Mar 2, 2026 | Mar 5 12:06 AM | Glendon E. French IIIDirector, President and CEO | Sale | 67,813 | $1.43 | $97.0K | 1,409,511(D) | View → |
| Mar 2, 2026 | Mar 5 12:04 AM | Geoffrey Beran RoseCHIEF COMMERCIAL OFFICER | Sale | 7,732 | $1.43 | $11.1K | 365,734(D) | View → |
| Mar 2, 2026 | Mar 5 12:01 AM | David Aaron LehmanGENERAL COUNSEL | Sale | 12,237 | $1.43 | $17.5K | 240,755(D) | View → |
Stock Options & Derivatives
No transactions found.